
|Articles|March 15, 2003
FDA seeks innovation, shorter review process
Washington, DC-The FDA is proposing a set of guidelines geared toward improving the development and availability of new drugs and medical devices.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR, Broadwood reach cooperation agreement, restructure board after terminated Alcon deal
2
Ophthalmology pipeline watch: Key trial results and PDUFA dates for Q1 2026
3
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
4
PRIMA retinal implant restores vision in patients with advanced GA
5














































